Pain reliever to prevent pancreas inflammation after ERCP
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether giving an anti-inflammatory drug (diclofenac) before an ERCP procedure can help prevent a common complication called pancreatitis (inflammation of the pancreas). If you are scheduled for ERCP, you may be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for an ERCP, a procedure that looks at your bile and pancreatic ducts.
- You must not be allergic or intolerant to NSAIDs, such as ibuprofen or naproxen.
- You must not be taking NSAIDs every day.
- You must not have severe heart failure, kidney failure, or a bleeding disorder.
- You must not have a history of bleeding stomach ulcers or have had an abdominoperineal resection (a type of rectal cancer surgery).
- You must not be pregnant, and you must be able to understand Swedish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two common NSAID medications (indomethacin and diclofenac) given before an ERCP procedure to see if one is better at preventing pancreatitis, a common complication. If you are having an ERCP and meet the health criteria, you may be able to join.
This study tests whether combining a rectal anti-inflammatory medication (indomethacin) with cold water cooling of the pancreas opening during an endoscopic procedure can better prevent pancreatitis—a painful inflammation of the pancreas—compared to medication alone.
This trial tests if applying cold therapy or giving an NSAID (anti-inflammatory medication) before an ERCP can prevent pancreatitis, a common complication. It is for adults having their first ERCP.
This trial tests whether using rectal NSAIDs (a type of painkiller) with or without a small tube (stent) in the pancreas can prevent pancreatitis after ERCP. It's for people who are at higher risk for this complication.
This Phase 3 study tests whether putting an anti-inflammatory medicine into the rectum (indomethacin) plus taking an immune-suppressing pill (tacrolimus) works better than using the two medicines in a different combination to prevent pancreatitis after an ERCP procedure. If you qualify, you may be assigned to one of the treatment options to lower your risk of post-ERCP pancreas inflammation.
This study tests whether a rectal dose of indomethacin (an anti-inflammatory drug) can help prevent complications after an ERCP. It is for people who have already had a sphincterotomy and are having another ERCP to treat bile duct issues.
Hear when a new Common Bile Duct Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.